Halozyme Therapeutics (Nasdaq:HALO) is a biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.
Recent Mentions on Fool.com
- Why Halozyme Therapeutics Inc. Shares Surged
- This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
- Why Bio-Reference Laboratories, Ciena, and Halozyme Therapeutics Are Today's 3 Best Stocks
- Why Halozyme Therapeutics Inc. Shares Soared
- The Biggest Biotech Wins of the Week